These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 9384697)
1. Detection of minimal residual disease in acute leukemia patients. van Dongen JJ; Szczepański T; de Bruijn MA; van den Beemd MW; de Bruin-Versteeg S; Wijkhuijs JM; Tibbe GJ; van Gastel-Mol EJ; Groeneveld K; Hooijkaas H Cytokines Mol Ther; 1996 Jun; 2(2):121-33. PubMed ID: 9384697 [TBL] [Abstract][Full Text] [Related]
2. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. van Dongen JJ; Breit TM; Adriaansen HJ; Beishuizen A; Hooijkaas H Leukemia; 1992; 6 Suppl 1():47-59. PubMed ID: 1548936 [TBL] [Abstract][Full Text] [Related]
3. Detection of minimal residual disease in acute leukemia. van der Velden VH; Boeckx N; van Wering ER; van Dongen JJ J Biol Regul Homeost Agents; 2004; 18(2):146-54. PubMed ID: 15471219 [TBL] [Abstract][Full Text] [Related]
4. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology. Nakao M; Janssen JW; Flohr T; Bartram CR Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322 [TBL] [Abstract][Full Text] [Related]
5. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia. Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540 [TBL] [Abstract][Full Text] [Related]
6. [Tandem application of flow cytometry and polymerase chain reaction for choice targets of minimal residual disease in childhood acute lymphoblastic leukemia]. Tie LJ; Gu LJ; Jiang LM; Zhao JC; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):246-50. PubMed ID: 19374803 [TBL] [Abstract][Full Text] [Related]
7. MRD detection in acute lymphoblastic leukemia patients using Ig/TCR gene rearrangements as targets for real-time quantitative PCR. van der Velden VH; van Dongen JJ Methods Mol Biol; 2009; 538():115-50. PubMed ID: 19277574 [TBL] [Abstract][Full Text] [Related]
8. Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR. Kerst G; Kreyenberg H; Roth C; Well C; Dietz K; Coustan-Smith E; Campana D; Koscielniak E; Niemeyer C; Schlegel PG; Müller I; Niethammer D; Bader P Br J Haematol; 2005 Mar; 128(6):774-82. PubMed ID: 15755280 [TBL] [Abstract][Full Text] [Related]
9. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. van der Velden VH; Hochhaus A; Cazzaniga G; Szczepanski T; Gabert J; van Dongen JJ Leukemia; 2003 Jun; 17(6):1013-34. PubMed ID: 12764363 [TBL] [Abstract][Full Text] [Related]
10. Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006. Thörn I; Forestier E; Thuresson B; Wasslavik C; Malec M; Li A; Lindström-Eriksson E; Botling J; Barbany G; Jacobsson S; Olofsson T; Porwit A; Sundström C; Rosenquist R Eur J Haematol; 2010 Feb; 84(2):117-27. PubMed ID: 19895569 [TBL] [Abstract][Full Text] [Related]
11. Four-color flow cytometry bypasses limitations of IG/TCR polymerase chain reaction for minimal residual disease detection in certain subsets of children with acute lymphoblastic leukemia. Robillard N; Cavé H; Méchinaud F; Guidal C; Garnache-Ottou F; Rohrlich PS; Avet-Loiseau H; Garand R Haematologica; 2005 Nov; 90(11):1516-23. PubMed ID: 16266899 [TBL] [Abstract][Full Text] [Related]
12. Molecular monitoring of childhood acute lymphoblastic leukemia using antigen receptor gene rearrangements and quantitative polymerase chain reaction technology. Cazzaniga G; Biondi A Haematologica; 2005 Mar; 90(3):382-90. PubMed ID: 15749670 [TBL] [Abstract][Full Text] [Related]
13. Monitoring of minimal residual disease in leukemia, advantages and pitfalls. Cazzaniga G; Gaipa G; Rossi V; Biondi A Ann Med; 2006; 38(7):512-21. PubMed ID: 17101542 [TBL] [Abstract][Full Text] [Related]
14. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia. Muñoz L; López O; Martino R; Brunet S; Bellido M; Rubiol E; Sierra J; Nomdedéu JF Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122 [TBL] [Abstract][Full Text] [Related]